Patents

US 8987295 B2: Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof

Granted
2015-03-24
Filed
2012-12-06 application 13707265
Type
Utility · 22 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention is directed to substituted azoanthracene derivatives or pharmaceutically acceptable salts thereof that modulate the human GLP-1 receptor and that may be useful in the treatment of diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial, such as diabetes mellitus type 2. The invention is also directed to pharmaceutical compositions comprising these compounds and to the use of these compounds and compositions in the treatment of such diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial.

Source: PVGPATDIS, file of 2026-04-10 (ipg150324.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
TransTech Pharma, LLC 28 patentsUS company or organizationHigh Point, NCPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Adnan M. M. MjalliOak Ridge, NC53PVGPATDIS, file of 2026-04-10
Christopher BehmeJamestown, NC10PVGPATDIS, file of 2026-04-10
Daniel P. ChristenJamestown, NC10PVGPATDIS, file of 2026-04-10
Devi Reddy GohimukkulaJamestown, NC10PVGPATDIS, file of 2026-04-10
Dharma Rao PolisettiHigh Point, NC49PVGPATDIS, file of 2026-04-10
James C. Quada, Jr.High Point, NC5PVGPATDIS, file of 2026-04-10
Jennifer FreemanWinston-Salem, NC11PVGPATDIS, file of 2026-04-10
Kalpathy SanthoshJamestown, NC13PVGPATDIS, file of 2026-04-10
Muralidhar BondlelaGreensboro, NC7PVGPATDIS, file of 2026-04-10
Mustafa GuzelJamestown, NC32PVGPATDIS, file of 2026-04-10
Ravindra Reddy YarraguntaGreensboro, NC5PVGPATDIS, file of 2026-04-10
Robert Carl AndrewsJamestown, NC39PVGPATDIS, file of 2026-04-10
Stephen Thomas DavisDurham, NC17PVGPATDIS, file of 2026-04-10
Thomas Scott YokumGreensboro, NC11PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D491/056PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P3/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2021-01-27Release of security interest
Release of security interest
HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT signed 2021-01-21VTV THERAPEUTICS LLC HIGH POINT, NC55133/214PASDL, file of 2026-10-15
2018-04-18Security interest Security interest
Security interest
VTV THERAPEUTICS LLC signed 2018-04-09HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT FARMINGTON, CT45969/774PASDL, file of 2026-10-15
2015-09-24Correction
Corrective assignment to correct the receiving party data previously recorded at reel: 036254 frame: 0780. assignor(s) hereby confirms the assignment.
M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT signed 2015-07-29VTVX HOLDINGS I LLC HIGH POINT, NC36675/407ECORSEXC, file of 2026-09-25
2015-08-03Release of security interest
Release of security interest
M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT signed 2015-07-29VTVX HOLDINGS II LLC HIGH POINT, NC36254/780ECORSEXC, file of 2026-09-25
2015-07-31Assignment
Assignment of assignor's interest
VTVX HOLDINGS I LLC signed 2015-07-29VTV THERAPEUTICS LLC HIGH POINT, NC36242/354ECORSEXC, file of 2026-09-25
2015-07-30Name change
Change of name
VTV THERAPEUTICS LLC signed 2015-07-29VTVX HOLDINGS I LLC HIGH POINT, NC36236/165ECORSEXC, file of 2026-09-25
2015-06-25Name change
Change of name
TRANSTECH PHARMA, LLC signed 2015-05-18VTV THERAPEUTICS LLC HIGH POINT, NC36026/219ECORSEXC, file of 2026-09-25
2015-02-26Security interest Security interest
Security interest
TRANSTECH PHARMA, LLC signed 2015-02-25M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT NEW YORK, NY35103/356ECORSEXC, file of 2026-09-25
2014-04-07Release of security interest
Notice of release of security interest in patents for reel/frame 030982/0803
M&F TTP HOLDINGS LLC signed 2014-03-28TRANSTECH PHARMA, LLC HIGH POINT, NC32621/860ECORSEXC, file of 2026-09-25
2013-11-26Assignment
Assignment of assignor's interest
TRANSTECH PHARMA, INC. signed 2013-11-14TRANSTECH PHARMA, LLC HIGH POINT, NC31678/682ECORSEXC, file of 2026-09-25
2013-08-09Security interest Security interest
Security agreement
TRANSTECH PHARMA, INC. signed 2013-08-09M&F TTP HOLDINGS LLC C/O MACANDREWS & FORBES HOLDINGS INC. NEW YORK, NY30982/803ECORSEXC, file of 2026-09-25
2013-01-11Assignment
Assignment of assignor's interest
BEHME, CHRISTOPHER signed 2009-01-16
FREEMAN, JENNIFER L.R. signed 2010-07-27
GOHIMUKKULA, DEVI REDDY signed 2010-07-27
YOKUM, THOMAS SCOTT signed 2010-07-27
BONDLELA, MURALIDHAR signed 2010-07-28
POLISETTI, DHARMA RAO signed 2010-07-28
SANTHOSH, KALPATHY signed 2010-07-28
DAVIS, STEPHEN THOMAS signed 2010-07-30
ANDREWS, ROBERT CARL signed 2010-08-02
GUZEL, MUSTAFA signed 2010-08-02
QUADA, JAMES signed 2010-08-02
YARRAGUNTA, RAVINDRA REDDY signed 2010-08-02
MJALLI, ADNAN M.M. signed 2010-08-03
CHRISTEN, DANIEL P. signed 2010-08-19
TRANSTECH PHARMA, INC. HIGH POINT, NC29615/1ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.